These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 15304)

  • 1. Studies on membrane receptor sites for serotonin in the brain.
    Ungar F; Callaghan OH
    Res Commun Chem Pathol Pharmacol; 1977 Feb; 16(2):205-24. PubMed ID: 15304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subsynaptosomal localization and biochemical characterization of serotonin binding sites in the brain.
    Ungar F; Callaghan OH; Arora RC; Alivisatos SG
    Res Commun Chem Pathol Pharmacol; 1976 Nov; 15(3):409-24. PubMed ID: 186852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of monoamine oxidase inhibitors on the borohydride stabilizable binding of serotonin and tryptamine in brain.
    Ungar F; Callaghan OH
    Res Commun Chem Pathol Pharmacol; 1977 Jun; 17(2):191-9. PubMed ID: 877408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrimination in 5-HT(3) receptor binding in murine brain and cultured cell preparations.
    Zhang ZJ; Trivedi BL; de Paulis T; Schmidt DE; Hewlett WA
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):123-32. PubMed ID: 11819030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary studies of the sodium borohydride stabilizable binding of phenylethylamine and tyramine to brain preparations.
    Ungar F; Mosnaim AD; Ungar B; Wolf ME
    Res Commun Chem Pathol Pharmacol; 1978 Mar; 19(3):427-34. PubMed ID: 653100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo binding properties of [carbonyl-11C]WAY-100635: effect of endogenous serotonin.
    Maeda J; Suhara T; Ogawa M; Okauchi T; Kawabe K; Zhang MR; Semba J; Suzuki K
    Synapse; 2001 May; 40(2):122-9. PubMed ID: 11252023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug antagonism and reversibility of the binding of indoleamines in brain.
    Ungar F; Hitri A; Alivisatos SG
    Eur J Pharmacol; 1976 Mar; 36(1):115-25. PubMed ID: 1063074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subsynaptosomal distribution, inhibition, and characterization of the binding of (14C) 5-OH-indole-3-acetaldehyde to brain preparations.
    Ungar F; Alivisatos SG
    Res Commun Chem Pathol Pharmacol; 1976 Mar; 13(3):449-64. PubMed ID: 7005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical characterization of [3H]tryptamine binding sites from rat brain.
    Brüning G; Rommelspacher H
    Biochem Int; 1989 Jan; 18(1):227-33. PubMed ID: 2541722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotoninergic receptors in brain tissue: properties and identification of various 3H-ligand binding sites in vitro.
    Leysen JE
    J Physiol (Paris); 1981; 77(2-3):351-62. PubMed ID: 7288650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain.
    Stratford CA; Tan GL; Hamblin MW; Ciaranello RD
    Mol Pharmacol; 1988 Oct; 34(4):527-36. PubMed ID: 3139989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interaction of indoleamines with serotonergic receptors of brain synaptosomes].
    Uzbekov MG; Bernshtein KhG
    Biokhimiia; 1980 Jan; 45(1):109-12. PubMed ID: 7213827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of the 5-hydroxytryptamine2C receptor protein in adult rat brain and spinal cord determined using a receptor-directed antibody: effect of 5,7-dihydroxytryptamine.
    Sharma A; Punhani T; Fone KC
    Synapse; 1997 Sep; 27(1):45-56. PubMed ID: 9268064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT and LSD high affinity binding sites to brain synaptosomal membranes [proceedings].
    Fillion G; Fillion MP; Jacob J; Rousselle JC
    Br J Pharmacol; 1976 Nov; 58(3):425P-426P. PubMed ID: 990612
    [No Abstract]   [Full Text] [Related]  

  • 15. [3H]dihydroergotamine as a high-affinity, slowly dissociating radioligand for 5-HT1B binding sites in rat brain membranes: evidence for guanine nucleotide regulation of agonist affinity states.
    Hamblin MW; Ariani K; Adriaenssens PI; Ciaranello RD
    J Pharmacol Exp Ther; 1987 Dec; 243(3):989-1001. PubMed ID: 2826763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional distribution and cellular localization of 5-HT2C receptor mRNA in monkey brain: comparison with [3H]mesulergine binding sites and choline acetyltransferase mRNA.
    López-Giménez JF; Mengod G; Palacios JM; Vilaró MT
    Synapse; 2001 Oct; 42(1):12-26. PubMed ID: 11668587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple 3H-5-hydroxytryptamine binding sites in rat brain.
    Nelson DL; Pedigo NW; Yamamura HI
    J Physiol (Paris); 1981; 77(2-3):369-72. PubMed ID: 7288652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in and modulation of receptor activity in hepatic encephalopathy].
    Kienzl E; Riederer P; Brücke T; Kleinberger G; Jellinger K
    Infusionsther Klin Ernahr; 1985 Feb; 12(1):32, 37-45. PubMed ID: 2859245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of serotonin 5-HT(4) receptor mRNA and ligand binding sites in the post-mortem human brain.
    Bonaventure P; Hall H; Gommeren W; Cras P; Langlois X; Jurzak M; Leysen JE
    Synapse; 2000 Apr; 36(1):35-46. PubMed ID: 10700024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.
    Massot O; Rousselle JC; Fillion MP; Grimaldi B; Cloëz-Tayarani I; Fugelli A; Prudhomme N; Seguin L; Rousseau B; Plantefol M; Hen R; Fillion G
    Mol Pharmacol; 1996 Oct; 50(4):752-62. PubMed ID: 8863819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.